Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-160X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies ; day:18 ; month:2 ; year:2016 ; pages:1-10
Rheumatology international ; (18.2.2016), 1-10
- Creator
-
Elyoussfi, Sarah
- Contributor
-
Thomas, Benjamin J.
Ciurtin, Coziana
SpringerLink (Online service)
- DOI
-
10.1007/s00296-016-3436-0
- URN
-
urn:nbn:de:1111-2016022012196
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elyoussfi, Sarah
- Thomas, Benjamin J.
- Ciurtin, Coziana
- SpringerLink (Online service)
Other Objects (12)
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Psoriasis and psoriatic arthritis : an integrated approach
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Psoriasis and psoriatic arthritis : an integrated approach
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Psoriasis and psoriatic arthritis : an integrated approach
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Oral microbiota diversity in moderate to severe plaque psoriasis, nail psoriasis and psoriatic arthritis
Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis
Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)